We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$377B
AUM Growth
+$49.7B
Cap. Flow
+$31.3B
Cap. Flow %
8.3%
Top 10 Hldgs %
41.14%
Holding
5,593
New
785
Increased
2,954
Reduced
1,009
Closed
322

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Financials 7.13%
3 Consumer Discretionary 6.46%
4 Healthcare 5.43%
5 Communication Services 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBON icon
4951
Ebang International Holdings
EBON
$12.6M
$969 ﹤0.01%
161
ZSL icon
4952
ProShares UltraShort Silver
ZSL
$67M
$839 ﹤0.01%
2
PHUN icon
4953
Phunware
PHUN
$42.9M
$838 ﹤0.01%
245
-559
-70% -$2.26K
MVST icon
4954
Microvast
MVST
$237M
$811 ﹤0.01%
3,252
-46,936
-94% -$15.7K
IPHA
4955
Innate Pharma
IPHA
$171M
$703 ﹤0.01%
307
-105
-25% -$232
TOVX icon
4956
Theriva Biologics
TOVX
$10.1M
$683 ﹤0.01%
+495
New +$2.42K
MTEM
4957
DELISTED
Molecular Templates, Inc.
MTEM
$668 ﹤0.01%
475
ME
4958
DELISTED
23andMe Holding Co
ME
$649 ﹤0.01%
93
+57
+158% +$425
NBTX
4959
Nanobiotix
NBTX
$1.92B
$633 ﹤0.01%
110
GWH icon
4960
ESS Tech
GWH
$21M
$632 ﹤0.01%
100
-3,720
-97% -$33.7K
NA
4961
Nano Labs
NA
$42.2M
$585 ﹤0.01%
76
USL icon
4962
United States 12 Month Oil Fund,
USL
$45.7M
$575 ﹤0.01%
16
IMVP
4963
Invesco India ETF
IMVP
$124M
$553 ﹤0.01%
18
-7
-28% -$209
ARKF icon
4964
ARK Blockchain & Fintech Innovation ETF
ARKF
$731M
$536 ﹤0.01%
18
+3
+20% +$84
MRNS
4965
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$531 ﹤0.01%
302
-36,097
-99% -$50.4K
VOD icon
4966
Vodafone
VOD
$37.1B
$521 ﹤0.01%
52
DRV icon
4967
Direxion Daily Real Estate Bear 3X ETF
DRV
$25M
$509 ﹤0.01%
22
PSEC icon
4968
Prospect Capital
PSEC
$1.08B
$476 ﹤0.01%
89
DZSI
4969
DELISTED
DZS Inc. Common Stock
DZSI
$457 ﹤0.01%
725
-6,841
-90% -$8.23K
LONA
4970
LeonaBio Inc
LONA
$66.1M
$452 ﹤0.01%
101
-10,206
-99% -$239K
DRN icon
4971
Direxion Daily Real Estate Bull 3X ETF
DRN
$48.5M
$441 ﹤0.01%
33
ERY icon
4972
Direxion Daily Energy Bear 2X ETF
ERY
$40.3M
$438 ﹤0.01%
18
QID icon
4973
ProShares UltraShort QQQ
QID
$305M
$434 ﹤0.01%
12
PDYN icon
4974
Palladyne AI
PDYN
$228M
$419 ﹤0.01%
234
-32
-12% -$57
EWD icon
4975
iShares MSCI Sweden ETF
EWD
$534M
$391 ﹤0.01%
9

Similar funds

Barclays's Q3 2024 Portfolio in Review

As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.

  • Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
  • Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
  • Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
  • Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
  • Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
  • Barclays opened 785 new positions and closed 322 in Q3 2024.
  • Barclays's portfolio value rose 15% quarter-over-quarter to $377B.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.